Autori: Andric Zoran G
| Naslov | Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON) (Article) |
| Autori | Tobias Joshua ... Andric Zoran G  ... Nikolic Ivan V Petrovic Zoran ... (broj koautora 17)
|
| Info | CLINICAL CANCER RESEARCH, (2024), vol. 30 br. 18, str. 4044-4054 |
| Projekat | Imugene Ltd. |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
     |
| Naslov | Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study (Article) |
| Autori | Reck Martin ... Andric Zoran G ... (broj koautora 24)
|
| Info | LUNG CANCER, (2024), vol. 196 br. , str. - |
| Projekat | F. Hoffmann-La Roche Ltd. |
| Ispravka | Web of Science Članak Elečas Rang časopisa |
|
|
| Naslov | RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer (Article) |
| Autori | Spigel David R ... Stojanovic Goran ... Andric Zoran G ... (broj koautora 17)
|
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2024), vol. 42 br. 19, str. - |
| Projekat | Ipsen |
| Ispravka | Web of Science Članak Elečas Rang časopisa |
|
|
| Naslov | Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial (Article) |
| Autori | Reck Martin ... Andric Zoran G ... (broj koautora 18)
|
| Info | JOURNAL OF THORACIC ONCOLOGY, (2024), vol. 19 br. 2, str. 297-313 |
| Projekat | Healthcare business of Merck KGaA, Darmstadt, Germany; Pfizer |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
|
| Naslov | Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study (Article) |
| Autori | Leal Ticiana A ... Andric Zoran G ... (broj koautora 25)
|
| Info | LANCET ONCOLOGY, (2023), vol. 24 br. 9, str. 1002-1017 |
| Projekat | Novocure |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial (Article) |
| Autori | Verschraegen Claire Andric Zoran G Moiseenko Fedor Makharadze Tamta Shevnya Sergii Oleksiienko Alona Ruiz Eduardo Yanez Kim SungHyun Ahn KeumYoung Park TaeHong Park Sijin Ju Hana Ohe Yuichiro
|
| Info | BIODRUGS, (2022), vol. 36 br. 6, str. 749-760 |
| Projekat | Celltrion, Inc. (Incheon, Republic of Korea) |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2 (Article) |
| Autori | Goel Shom Tan Antoinette R Rugo Hope S Aftimos Philippe Andric Zoran G Beelen Andrew Paul Zhang Jingshan Yi John S Malik Rajesh K O'Shaughnessy Joyce
|
| Info | FUTURE ONCOLOGY, (2022), vol. 18 br. 33, str. 3701-3711 |
| Projekat | G1 Therapeutics; Eli Lilly; Merck; Pfizer; AstraZeneca; Ayala; Boehringer Ingelheim; Daiichi; Gilead; Lilly; Macrogenics; Novartis; OBI; Odonate; Polyphor; Roche; Seattle Genetics; Sermonix |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial (Article) |
| Autori | Peters Solange ... Andric Zoran G ... (broj koautora 26)
|
| Info | NATURE MEDICINE, (2022), vol. 28 br. 9, str. 1831-+ |
| Projekat | F. Hoffmann-La Roche, Ltd. |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Overweight and obesity in polycystic ovary syndrome: association with inflammation, oxidative stress and dyslipidaemia (Article) |
| Autori | Perovic-Blagojevic Iva M Vekic Jelena Z Macut Djuro P Ignjatovic Svetlana D Miljkovic-Trailovic Milica M Zeljkovic Aleksandra R Spasojevic-Kalimanovska Vesna V Bozic-Antic Ivana B Bjekic-Macut Jelica D Kastratovic-Kotlica Biljana A Andric Zoran G Ilic Dusan S Kotur-Stevuljevic Jelena M
|
| Info | BRITISH JOURNAL OF NUTRITION, (2022), vol. 128 br. 4, str. 604-612 |
| Projekat | Serbian Ministry of Science and Education [200110, 451-03-9/2021-14/200161] |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies (Article) |
| Autori | Weiss Jared Goldschmidt Jerome Andric Zoran G Dragnev Konstantin H Gwaltney Chad Skaltsa Konstantina Pritchett Yili Antal Joyce M Morris Shannon R Daniel Davey
|
| Info | CLINICAL LUNG CANCER, (2021), vol. 22 br. 5, str. 449-460 |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
